Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00415948 · ClinicalTrials.gov registry record
Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement
A clinical trial of Acute Coronary Syndrome (ACS), sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 300
- Enrollment target
- 18
- Study locations
NCT00415948: Completed study of Acute Coronary Syndrome (ACS), sponsored by Abbott RDx Cardiometabolic.
NCT00415948 is a study of Acute Coronary Syndrome (ACS) that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 300 participants. The trial reports 18 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00415948, a study of Acute Coronary Syndrome (ACS), has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 18
- Study locations
Study Summary
The purpose of the study is to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome).
Conditions Studied
Interventions
- DEVICE Biomarkers
Study Locations (18)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Brigham & Women's Hospital - Boston
- Massachusetts General Hospital - Boston
Michigan
- Henry Ford Health System - Detroit
- Spectrum Health Hospitals - Grand Rapids
- Ingham Regional Medical Center - Lansing
Virginia
- University of Virginia - Charlottesville
- Sentara Norfolk General Hopsital - Norfolk
- Virginia Commonwealth University Medical Center - Richmond
New York
- New York Methodist Hosptial - Brooklyn
- SUNY Stony Brook - Stony Brook
North Carolina
- Duke University Medical Center - Durham
- Wake Forest University School of Medicine - Winston-Salem
Ohio
- Cleveland Clinic Foundation - Cleveland
- Ohio State University Medical Center - Columbus
California
- UC Davis - Sacramento
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2006-12 |
| Est. Completion | 2008-06 |
What the finished NCT00415948 record still lists
NCT00415948 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Acute Coronary Syndrome (ACS) appearing as the primary indexed condition, and to 1 intervention - of which Biomarkers is the first listed.
NCT00415948 lists 18 locations in 9 states (Massachusetts, Michigan, Virginia).
Frequently Asked Questions
What is clinical trial NCT00415948 about?
NCT00415948 is a clinical study titled "Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement". The purpose of the study is to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome).
What is the current status of trial NCT00415948?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2006-12. Estimated completion is 2008-06.
What conditions does trial NCT00415948 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome (ACS).
What interventions are being tested in trial NCT00415948?
The interventions under investigation include: Biomarkers (DEVICE).
Who is sponsoring clinical trial NCT00415948?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00415948 being conducted?
This trial has 18 study locations across California, Connecticut, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome (ACS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia